Zenas BioPharma, Inc 10-Q for FY2024 Q3
Zenas BioPharma, Inc. (ZBIO)
10-Q
2024-11-12
For: 2024-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Zenas BioPharma, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).
Headline figures
Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $38.61M
- compared with net income of $35.61M a year earlier
- Diluted EPS
- -$5.02
- compared with $1.96 a year earlier